Bilateral Thalamic Lesions Associated With Atezolizumab-Induced Encephalitis: A Follow-up Report With Autopsy Findings

Affiliations

• ¹ From the Departments of Neurology (H.N., T.K., C.S., T.N., M.T.) and Neuropathology (K.W.), Institute of Brain Science, and Departments of Respiratory Medicine (H.T.) and Neuropsychiatry (Y. Sakamoto), Hirosaki University Graduate School of Medicine; Department of Neurology (H.N., T.N.), Hirosaki University Hospital; and Department of Neurology (Y. Seino) and Division of Pathology and Clinical Laboratory (N.Y.), Hirosaki National Hospital, Hirosaki City, Japan. haruonishijima@gmail.com.
• ² From the Departments of Neurology (H.N., T.K., C.S., T.N., M.T.) and Neuropathology (K.W.), Institute of Brain Science, and Departments of Respiratory Medicine (H.T.) and Neuropsychiatry (Y. Sakamoto), Hirosaki University Graduate School of Medicine; Department of Neurology (H.N., T.N.), Hirosaki University Hospital; and Department of Neurology (Y. Seino) and Division of Pathology and Clinical Laboratory (N.Y.), Hirosaki National Hospital, Hirosaki City, Japan.